about
CTLA-4 and PD-L1 checkpoint blockade enhances oncolytic measles virus therapy.Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells.Two immune faces of pancreatic adenocarcinoma: possible implication for immunotherapy.Extracellular adenosine metabolism in immune cells in melanoma.Retroviral Transduction of Bone Marrow Progenitor Cells to Generate T-cell Receptor Retrogenic Mice.Cutting Edge: Low-Affinity TCRs Support Regulatory T Cell Function in Autoimmunity.Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer.Comment on "Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b(+)Gr1(+) cells"
P50
Q35600445-57A2038B-0C16-4238-B7B4-7B037297E610Q35799021-746129E5-99B3-43FB-98E8-3ED468C53DE1Q38152980-5BF29916-42EF-41E9-9BC5-BE9DC82BAE74Q38206399-6FC55FD2-762E-44FC-8B1F-5A0E677BB16CQ40631295-BE6C0EF2-FE3C-4717-9E5E-6A9BC541CDA5Q48340543-D0D7AA9E-09D9-410D-BE03-B5125E59C100Q50924443-0E5152B0-54D6-4340-A5FF-8F67004C962FQ83733415-4C3C1FCE-1B5A-4D67-8D3B-74E8ECB848A7
P50
description
researcher ORCID ID = 0000-0002-6222-6553
@en
wetenschapper
@nl
name
Ivan Shevchenko
@ast
Ivan Shevchenko
@en
Ivan Shevchenko
@es
Ivan Shevchenko
@nl
type
label
Ivan Shevchenko
@ast
Ivan Shevchenko
@en
Ivan Shevchenko
@es
Ivan Shevchenko
@nl
prefLabel
Ivan Shevchenko
@ast
Ivan Shevchenko
@en
Ivan Shevchenko
@es
Ivan Shevchenko
@nl
P106
P21
P31
P496
0000-0002-6222-6553